UBS Maintains Zoetis(ZTS.US) With Hold Rating, Cuts Target Price to $170
New Analyst Forecast: $ZTS Given $170.0 Price Target
Zoetis (NYSE:ZTS) Q1 Earnings Increase With Sales At US$2220 Million
Zoetis Is Maintained at Neutral by UBS
Zoetis Analyst Ratings
BofA Securities Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $200
Express News | Zoetis Inc : UBS Cuts Target Price to $170 From $189
Zoetis: Strong Financial Performance and Growth Potential Justify Buy Rating
Zoetis Reports Modest Revenue Growth in Q1 2025
William Blair Initiates Zoetis(ZTS.US) With Buy Rating
Leerink Partners Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $180
Zoetis Earnings Call: Strong Growth Amid Challenges
Zoetis | 10-Q: Q1 2025 Earnings Report
Earnings Call Summary | Zoetis(ZTS.US) Q1 2025 Earnings Conference
Zoetis Maintains 6%-8% Revenue Growth Guidance for 2025 While Targeting Double-digit Growth in Key Franchises
Research Alert: CFRA Retains Hold View On Shares Of Zoetis Inc.
Express News | Zoetis Shares Fall 3.5% After Q1 Results
Compared to Estimates, Zoetis (ZTS) Q1 Earnings: A Look at Key Metrics
Express News | Zoetis Exec Says Co Has Advocated to the U.S. Administration That Animal Health Products Should Be Excluded From Broader Sector Tariffs
Express News | Zoetis Exec Says Co Has Not Seen Any Delays or Backlogs at FDA, Despite Work Cuts, and Is Continuing to Work on Pipeline Products